Skip to main content
Top
Published in: Acta Neurologica Belgica 6/2020

01-12-2020 | Generalized Anxiety Disorder | Original article

Anxiety is associated with increased risk for atrial cardiopathy

Authors: Zhaolu Wang, Huiyuan Qin, Guilin Chen, Yan Dai, Yingyuan Cai, Xi Cheng, Yun Qian, Ming Chu, Xiaowei Lu

Published in: Acta Neurologica Belgica | Issue 6/2020

Login to get access

Abstract

Anxiety is common in patients with atrial fibrillation (AF). The mutual causal effect between anxiety and AF is expected with limited evidence. Atrial cardiopathy is a term to describe structural or electrophysiological atrium abnormality that precedes the onset of AF. This study aimed to investigate the association of anxiety with atrial cardiopathy, giving a clue to the causal relationship of this mind–heart link. This cross-sectional study analyzed 532 patients who were free of AF, atrial flutter, stroke, acute coronary syndrome and valvular heart disease. Atrial cardiopathy was defined as P-wave terminal force in lead V1 > 5000 μV·ms on electrocardiogram or severe left atrial enlargement on echocardiogram. Generalized anxiety disorder was ascertained by a score of > 17/56 on Hamilton anxiety rating scale. Multivariable logistic regression was used to explore the association of anxiety with atrial cardiopathy. A total of 65(12.2%) patients had atrial cardiopathy and 53(10.0%) had generalized anxiety disorder, respectively. Those with atrial cardiopathy were older (74.0 vs 67.0, P < 0.001), had a bigger left ventricular posterior wall thickness (10.1 vs 9.7 mm, P = 0.030), and had a higher prevalence of hypertension (83.1% vs 65.5%, P = 0.005), premature complexes (20.0% vs 6.2%, P < 0.001), and generalized anxiety disorder (20.0% vs 8.6%, P = 0.004), respectively. Multivariable logistic regression showed the significant association of anxiety with atrial cardiopathy (OR 2.788; 95% CI 1.304–5.960, P = 0.008), independent of confounding factors. Anxiety is independently associated with atrial cardiopathy. This association indicates the triggering effect of anxiety on atrial remodeling.
Literature
1.
go back to reference Polikandrioti M, Koutelekos I, Vasilopoulos G, Gerogianni G, Gourni M et al (2018) Anxiety and depression in patients with permanent atrial fibrillation: prevalence and associated factors. Cardiol Res Pract 2018:7408129CrossRefPubMedPubMedCentral Polikandrioti M, Koutelekos I, Vasilopoulos G, Gerogianni G, Gourni M et al (2018) Anxiety and depression in patients with permanent atrial fibrillation: prevalence and associated factors. Cardiol Res Pract 2018:7408129CrossRefPubMedPubMedCentral
2.
go back to reference Patel D, Mc Conkey ND, Sohaney R, Mc Neil A, Jedrzejczyk A et al (2013) A systematic review of depression and anxiety in patients with atrial fibrillation: the mind-heart link. Cardiovasc Psychiatry Neurol 2013:159850CrossRefPubMedPubMedCentral Patel D, Mc Conkey ND, Sohaney R, Mc Neil A, Jedrzejczyk A et al (2013) A systematic review of depression and anxiety in patients with atrial fibrillation: the mind-heart link. Cardiovasc Psychiatry Neurol 2013:159850CrossRefPubMedPubMedCentral
3.
go back to reference Emdin CA, Odutayo A, Wong CX, Tran J, Hsiao AJ et al (2016) Meta-analysis of anxiety as a risk factor for cardiovascular disease. Am J Cardiol 118:511–519CrossRefPubMed Emdin CA, Odutayo A, Wong CX, Tran J, Hsiao AJ et al (2016) Meta-analysis of anxiety as a risk factor for cardiovascular disease. Am J Cardiol 118:511–519CrossRefPubMed
4.
go back to reference Severino P, Mariani MV, Maraone A, Piro A, Ceccacci A et al (2019) Triggers for atrial fibrillation: the role of anxiety. Cardiol Res Pract 2019:1208505PubMedPubMedCentral Severino P, Mariani MV, Maraone A, Piro A, Ceccacci A et al (2019) Triggers for atrial fibrillation: the role of anxiety. Cardiol Res Pract 2019:1208505PubMedPubMedCentral
5.
go back to reference Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA et al (2017) EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. Heart Rhythm 14:e3–e40CrossRefPubMed Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA et al (2017) EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. Heart Rhythm 14:e3–e40CrossRefPubMed
6.
go back to reference Kamel H, Okin PM, Longstreth WT Jr, Elkind MS, Soliman EZ (2015) Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation. Future Cardiol 11:323–331CrossRefPubMed Kamel H, Okin PM, Longstreth WT Jr, Elkind MS, Soliman EZ (2015) Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation. Future Cardiol 11:323–331CrossRefPubMed
7.
go back to reference Goldberger JJ, Arora R, Green D, Greenland P, Lee DC et al (2015) Evaluating the atrial myopathy underlying atrial fibrillation: identifying the arrhythmogenic and thrombogenic substrate. Circulation 132:278–291CrossRefPubMedPubMedCentral Goldberger JJ, Arora R, Green D, Greenland P, Lee DC et al (2015) Evaluating the atrial myopathy underlying atrial fibrillation: identifying the arrhythmogenic and thrombogenic substrate. Circulation 132:278–291CrossRefPubMedPubMedCentral
8.
go back to reference Kamel H, Bartz TM, Elkind MSV, Okin PM, Thacker EL et al (2018) Atrial cardiopathy and the risk of ischemic stroke in the CHS (cardiovascular health study). Stroke 49:980–986CrossRefPubMedPubMedCentral Kamel H, Bartz TM, Elkind MSV, Okin PM, Thacker EL et al (2018) Atrial cardiopathy and the risk of ischemic stroke in the CHS (cardiovascular health study). Stroke 49:980–986CrossRefPubMedPubMedCentral
9.
go back to reference Jalini S, Rajalingam R, Nisenbaum R, Javier AD, Woo A et al (2019) Atrial cardiopathy in patients with embolic strokes of unknown source and other stroke etiologies. Neurology 92:e288–e294CrossRefPubMed Jalini S, Rajalingam R, Nisenbaum R, Javier AD, Woo A et al (2019) Atrial cardiopathy in patients with embolic strokes of unknown source and other stroke etiologies. Neurology 92:e288–e294CrossRefPubMed
10.
go back to reference Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1–39):e14 Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1–39):e14
11.
go back to reference Turker Y, Ekinozu I, Aytekin S, Basar C, Baltaci D et al (2017) Comparison of changes in anxiety and depression level between dabigatran and warfarin use in patients with atrial fibrillation. Clin Appl Thromb Hemost 23:164–167CrossRefPubMed Turker Y, Ekinozu I, Aytekin S, Basar C, Baltaci D et al (2017) Comparison of changes in anxiety and depression level between dabigatran and warfarin use in patients with atrial fibrillation. Clin Appl Thromb Hemost 23:164–167CrossRefPubMed
12.
go back to reference Oksuz F, Yarlioglues M, Ozturk S, Kaya FD, Oksuz E et al (2017) Atrial electromechanical delay analysed by tissue Doppler echocardiography is prolonged in patients with generalised anxiety disorders. Kardiol Pol 75:581–588CrossRefPubMed Oksuz F, Yarlioglues M, Ozturk S, Kaya FD, Oksuz E et al (2017) Atrial electromechanical delay analysed by tissue Doppler echocardiography is prolonged in patients with generalised anxiety disorders. Kardiol Pol 75:581–588CrossRefPubMed
13.
go back to reference Hoge EA, Bui E, Marques L, Metcalf CA, Morris LK et al (2013) Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. J Clin Psychiatry 74:786–792CrossRefPubMedPubMedCentral Hoge EA, Bui E, Marques L, Metcalf CA, Morris LK et al (2013) Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. J Clin Psychiatry 74:786–792CrossRefPubMedPubMedCentral
14.
go back to reference Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ et al (2009) A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol 29:378–382CrossRefPubMedPubMedCentral Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ et al (2009) A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol 29:378–382CrossRefPubMedPubMedCentral
15.
go back to reference Thompson E (2015) Hamilton rating scale for anxiety (HAM-A). Occup Med (Lond) 65:601CrossRef Thompson E (2015) Hamilton rating scale for anxiety (HAM-A). Occup Med (Lond) 65:601CrossRef
16.
17.
go back to reference Wan GJ, Zhang HF, Tedeschi MA, Hackett D (2006) Estimation of symptom-free days in generalized anxiety disorder. Curr Med Res Opin 22:587–591CrossRefPubMed Wan GJ, Zhang HF, Tedeschi MA, Hackett D (2006) Estimation of symptom-free days in generalized anxiety disorder. Curr Med Res Opin 22:587–591CrossRefPubMed
18.
go back to reference de Lima AL, Braga FMA, da Costa RMM, Gomes EP, Brunoni AR et al (2019) Transcranial direct current stimulation for the treatment of generalized anxiety disorder: a randomized clinical trial. J Affect Disord 259:31–37CrossRefPubMed de Lima AL, Braga FMA, da Costa RMM, Gomes EP, Brunoni AR et al (2019) Transcranial direct current stimulation for the treatment of generalized anxiety disorder: a randomized clinical trial. J Affect Disord 259:31–37CrossRefPubMed
19.
go back to reference Morris JJ Jr, Estes EH Jr, Whalen RE, Thompson HK Jr, McIntosh HD (1964) P-Wave analysis in valvular heart disease. Circulation 29:242–252CrossRefPubMed Morris JJ Jr, Estes EH Jr, Whalen RE, Thompson HK Jr, McIntosh HD (1964) P-Wave analysis in valvular heart disease. Circulation 29:242–252CrossRefPubMed
20.
go back to reference Hopkins CB, Barrett O Jr (1989) Electrocardiographic diagnosis of left atrial enlargement. Role of the P terminal force in lead V1. J Electrocardiol 22:359–363CrossRefPubMed Hopkins CB, Barrett O Jr (1989) Electrocardiographic diagnosis of left atrial enlargement. Role of the P terminal force in lead V1. J Electrocardiol 22:359–363CrossRefPubMed
21.
go back to reference Goyal SB, Spodick DH (2001) Electromechanical dysfunction of the left atrium associated with interatrial block. Am Heart J 142:823–827CrossRefPubMed Goyal SB, Spodick DH (2001) Electromechanical dysfunction of the left atrium associated with interatrial block. Am Heart J 142:823–827CrossRefPubMed
22.
go back to reference Soliman EZ, Prineas RJ, Case LD, Zhang ZM, Goff DC Jr (2009) Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study. Stroke 40:1204–1211CrossRefPubMedPubMedCentral Soliman EZ, Prineas RJ, Case LD, Zhang ZM, Goff DC Jr (2009) Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study. Stroke 40:1204–1211CrossRefPubMedPubMedCentral
23.
go back to reference Njoku A, Kannabhiran M, Arora R, Reddy P, Gopinathannair R et al (2018) Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis. Europace 20:33–42CrossRefPubMed Njoku A, Kannabhiran M, Arora R, Reddy P, Gopinathannair R et al (2018) Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis. Europace 20:33–42CrossRefPubMed
24.
go back to reference Yaghi S, Moon YP, Mora-McLaughlin C, Willey JZ, Cheung K et al (2015) Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study. Stroke 46:1488–1493CrossRefPubMedPubMedCentral Yaghi S, Moon YP, Mora-McLaughlin C, Willey JZ, Cheung K et al (2015) Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study. Stroke 46:1488–1493CrossRefPubMedPubMedCentral
25.
go back to reference Barnes ME, Miyasaka Y, Seward JB, Gersh BJ, Rosales AG et al (2004) Left atrial volume in the prediction of first ischemic stroke in an elderly cohort without atrial fibrillation. Mayo Clin Proc 79:1008–1014CrossRefPubMed Barnes ME, Miyasaka Y, Seward JB, Gersh BJ, Rosales AG et al (2004) Left atrial volume in the prediction of first ischemic stroke in an elderly cohort without atrial fibrillation. Mayo Clin Proc 79:1008–1014CrossRefPubMed
26.
go back to reference Pohjavaara P, Telaranta T, Vaisanen E (2003) The role of the sympathetic nervous system in anxiety: is it possible to relieve anxiety with endoscopic sympathetic block? Nord J Psychiatry 57:55–60CrossRefPubMed Pohjavaara P, Telaranta T, Vaisanen E (2003) The role of the sympathetic nervous system in anxiety: is it possible to relieve anxiety with endoscopic sympathetic block? Nord J Psychiatry 57:55–60CrossRefPubMed
27.
go back to reference McKim DB, Patterson JM, Wohleb ES, Jarrett BL, Reader BF et al (2016) Sympathetic release of splenic monocytes promotes recurring anxiety following repeated social defeat. Biol Psychiatry 79:803–813CrossRefPubMed McKim DB, Patterson JM, Wohleb ES, Jarrett BL, Reader BF et al (2016) Sympathetic release of splenic monocytes promotes recurring anxiety following repeated social defeat. Biol Psychiatry 79:803–813CrossRefPubMed
28.
go back to reference Reeves JW, Fisher AJ, Newman MG, Granger DA (2016) Sympathetic and hypothalamic-pituitary-adrenal asymmetry in generalized anxiety disorder. Psychophysiology 53:951–957CrossRefPubMed Reeves JW, Fisher AJ, Newman MG, Granger DA (2016) Sympathetic and hypothalamic-pituitary-adrenal asymmetry in generalized anxiety disorder. Psychophysiology 53:951–957CrossRefPubMed
29.
go back to reference Liu F, Havens J, Yu Q, Wang G, Davisson RL et al (2012) The link between angiotensin II-mediated anxiety and mood disorders with NADPH oxidase-induced oxidative stress. Int J Physiol Pathophysiol Pharmacol 4:28–35PubMedPubMedCentral Liu F, Havens J, Yu Q, Wang G, Davisson RL et al (2012) The link between angiotensin II-mediated anxiety and mood disorders with NADPH oxidase-induced oxidative stress. Int J Physiol Pathophysiol Pharmacol 4:28–35PubMedPubMedCentral
30.
31.
go back to reference Murck H, Held K, Ziegenbein M, Kunzel H, Koch K et al (2003) The renin–angiotensin–aldosterone system in patients with depression compared to controls—a sleep endocrine study. BMC Psychiatry 3:15CrossRefPubMedPubMedCentral Murck H, Held K, Ziegenbein M, Kunzel H, Koch K et al (2003) The renin–angiotensin–aldosterone system in patients with depression compared to controls—a sleep endocrine study. BMC Psychiatry 3:15CrossRefPubMedPubMedCentral
32.
go back to reference Takahashi N, Kume O, Wakisaka O, Fukunaga N, Teshima Y et al (2012) Novel strategy to prevent atrial fibrosis and fibrillation. Circ J 76:2318–2326CrossRefPubMed Takahashi N, Kume O, Wakisaka O, Fukunaga N, Teshima Y et al (2012) Novel strategy to prevent atrial fibrosis and fibrillation. Circ J 76:2318–2326CrossRefPubMed
33.
go back to reference Nef HM, Mollmann H, Akashi YJ, Hamm CW (2010) Mechanisms of stress (Takotsubo) cardiomyopathy. Nat Rev Cardiol 7:187–193CrossRefPubMed Nef HM, Mollmann H, Akashi YJ, Hamm CW (2010) Mechanisms of stress (Takotsubo) cardiomyopathy. Nat Rev Cardiol 7:187–193CrossRefPubMed
35.
go back to reference Olson RD, Gambliel HA, Vestal RE, Shadle SE, Charlier HA Jr et al (2005) Doxorubicin cardiac dysfunction: effects on calcium regulatory proteins, sarcoplasmic reticulum, and triiodothyronine. Cardiovasc Toxicol 5:269–283CrossRefPubMed Olson RD, Gambliel HA, Vestal RE, Shadle SE, Charlier HA Jr et al (2005) Doxorubicin cardiac dysfunction: effects on calcium regulatory proteins, sarcoplasmic reticulum, and triiodothyronine. Cardiovasc Toxicol 5:269–283CrossRefPubMed
36.
go back to reference Severino P, Maestrini V, Mariani MV, Birtolo LI, Scarpati R et al (2020) Structural and myocardial dysfunction in heart failure beyond ejection fraction. Heart Fail Rev 25:9–17CrossRefPubMed Severino P, Maestrini V, Mariani MV, Birtolo LI, Scarpati R et al (2020) Structural and myocardial dysfunction in heart failure beyond ejection fraction. Heart Fail Rev 25:9–17CrossRefPubMed
Metadata
Title
Anxiety is associated with increased risk for atrial cardiopathy
Authors
Zhaolu Wang
Huiyuan Qin
Guilin Chen
Yan Dai
Yingyuan Cai
Xi Cheng
Yun Qian
Ming Chu
Xiaowei Lu
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Acta Neurologica Belgica / Issue 6/2020
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-020-01335-0

Other articles of this Issue 6/2020

Acta Neurologica Belgica 6/2020 Go to the issue